Article Details

Correvio Pharma Corp (CORV) Receives $8.17 Consensus Price Target from Analysts

Retrieved on: 2019-05-18 00:52:30

Tags for this article:

Click the tags to see associated articles and topics

Correvio Pharma Corp (CORV) Receives $8.17 Consensus Price Target from Analysts. View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC raised its holdings in shares of Correvio Pharma by 22.1% in the 3rd quarter. <b>Renaissance Technologies</b> LLC now ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up